Developing innovative and transformative cell-based technologies
Through our platform, we developed the Chimeric Antigen Receptor or CAR-T cell cancer immunotherapy for various types of cancers.
Through our platform, we developed the Chimeric Antigen Receptor or CAR-T cell cancer immunotherapy for various types of cancers.